To investigate the role of mortalin in breast cancer migration, breast cancer cells were transfected with either miR-Negative, miR-Mortalin, or exposed to anti-Mortalin antibody and assessed for transwell migration capability. This evidence concerns the gene HSPA9 and breast carcinoma.